TransCode Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 28 Sep 23 | BuyUS$49,980 | Robert Dudley | Individual | 2,450 | US$20.40 | |
| 28 Sep 23 | BuyUS$25,169 | Thomas Fitzgerald | Individual | 1,233.75 | US$20.40 | |
| 21 Jun 23 | BuyUS$48,665 | Robert Dudley | Individual | 465.18 | US$106.06 | |
| 09 Jun 23 | BuyUS$52,440 | Robert Dudley | Individual | 475 | US$110.40 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 137 | 0.00236% |
| Individual Insiders | 2,153 | 0.0371% |
| Institutions | 16,601 | 0.286% |
| General Public | 5,789,162 | 99.7% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 30781.5%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 7,047 | US$4.5k | 0% | no data | |||
| 4,685 | US$3.0k | 0% | no data | |||
| 1,941 | US$1.2k | 0% | no data | |||
| 1,305 | US$833.2 | 1,290% | no data | |||
| 1,250 | US$798.0 | 0% | no data | |||
| 874 | US$558.1 | 114% | no data | |||
| 657 | US$419.4 | 0% | no data | |||
| 274 | US$175.0 | 0% | no data | |||
| 268 | US$170.9 | 0% | no data | |||
| 196 | US$125.0 | -94.7% | no data | |||
| 137 | US$87.5 | 3.01% | no data | |||
| 113 | US$72.3 | -97.5% | no data | |||
| 60 | US$38.2 | -97.5% | no data | |||
| 40 | US$25.6 | 0% | no data | |||
| 35 | US$22.2 | -97.5% | no data | |||
| 4 | US$2.6 | -97.5% | no data | |||
| 3 | US$1.9 | 200% | no data | |||
| 1 | US$0.7 | 0% | no data | |||
| 1 | US$0.7 | 0% | no data |